Kinesiophobia, Physical Activity, Sleep, and Quality of Life in Women With Chronic Pelvic Pain

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-65
SponsorAhi Evran University Education and Research Hospital

About this trial

The study will include women who present to the Obstetrics and Gynecology outpatient clinic of Kırşehir Ahi Evran Training and Research Hospital with complaints of pelvic pain and are diagnosed with PCAS after a detailed examination, as well as healthy women. All included women will be administered the Tampa Kinesiophobia Scale (TKS), the International Physical Activity Questionnaire (Short), the Pittsburgh Sleep Quality Questionnaire (PSQI), and the Short Form 36 (p-36). The control group will consist of women who meet the inclusion and exclusion criteria but are not diagnosed with PCAS.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Being between 18-65 years of age

Having a diagnosis of Chronic Pelvic Pain

Having a pain score of 5 or higher on the visual analog scale

Voluntary participation in the study

Disqualifiers

Not wanting to continue in the study

Presence of neurological or orthopedic disease

Active urinary tract infection or recurrent urinary tract infection (more than 5 recurrent infections in the last 12 months)

Pregnancy

Trial population

women with chronic pelvic pain

Trial design

Design model

Case-control

Time perspective

Cross-sectional

Treatments tested in this trial

  • questionnaire

    Other intervention

    evaluation

Treatment groups

120 Participants
are divided into 2 treatment groups
Group A: chronic pelvic pain syndrome1 intervention
Group B: Healthy1 intervention

Trial outcomes

Primary outcomes

1

kinesiophobia

Kinesiophobia will be assessed using the Tampa Scale for Kinesiophobia (TSK). The scale consists of 17 items rated on a 4-point Likert scale. The total score ranges from 17 to 68, with higher scores indicating greater levels of kinesiophobia.

Time frame
At baseline (single assessment)

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.